Published in Am J Hum Genet on June 01, 1997
Techniques and pitfalls in the detection of pathogenic mitochondrial DNA mutations. J Mol Diagn (2003) 1.32
Detection of age-related duplications in mtDNA from human muscles and bones. Int J Legal Med (2010) 0.75
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Sequence and organization of the human mitochondrial genome. Nature (1981) 57.39
Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science (1989) 9.71
Diseases of the mitochondrial DNA. Annu Rev Biochem (1992) 6.29
Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med (1989) 4.87
mtDNA and the origin of Caucasians: identification of ancient Caucasian-specific haplogroups, one of which is prone to a recurrent somatic duplication in the D-loop region. Am J Hum Genet (1994) 4.47
Replication and transcription of vertebrate mitochondrial DNA. Annu Rev Cell Biol (1991) 3.17
Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucleic Acids Res (1990) 3.13
Priming of human mitochondrial DNA replication occurs at the light-strand promoter. Proc Natl Acad Sci U S A (1985) 3.05
Molecular genetic aspects of human mitochondrial disorders. Annu Rev Genet (1995) 2.82
Structure, chromosome location, and expression of the human gamma-actin gene: differential evolution, location, and expression of the cytoskeletal beta- and gamma-actin genes. Mol Cell Biol (1988) 2.62
Molecular analysis of cloned human 18S ribosomal DNA segments. Proc Natl Acad Sci U S A (1978) 2.29
Length heterogeneity of a conserved displacement-loop sequence in human mitochondrial DNA. Nucleic Acids Res (1985) 2.28
A human mitochondrial transcriptional activator can functionally replace a yeast mitochondrial HMG-box protein both in vivo and in vitro. Mol Cell Biol (1993) 2.27
Cytochrome c oxidase deficiency in Leigh syndrome. Ann Neurol (1987) 2.20
Distribution of wild-type and common deletion forms of mtDNA in normal and respiration-deficient muscle fibers from patients with mitochondrial myopathy. Hum Mol Genet (1994) 2.16
Late-onset mitochondrial myopathy. Ann Neurol (1995) 1.98
A transcription factor required for promoter recognition by human mitochondrial RNA polymerase. Accurate initiation at the heavy- and light-strand promoters dissected and reconstituted in vitro. J Biol Chem (1985) 1.86
Mitochondrial encephalomyopathies. Arch Neurol (1993) 1.79
Respiration and growth defects in transmitochondrial cell lines carrying the 11778 mutation associated with Leber's hereditary optic neuropathy. J Biol Chem (1996) 1.71
Length heteroplasmy of sturgeon mitochondrial DNA: an illegitimate elongation model. Genetics (1990) 1.65
Low levels of mitochondrial transcription factor A in mitochondrial DNA depletion. Biochem Biophys Res Commun (1994) 1.63
Mitochondrial diabetes revisited. Nat Genet (1994) 1.33
A tandem duplication in the D-loop of human mitochondrial DNA is associated with deletions in mitochondrial myopathies. Nat Genet (1993) 1.31
Families of mtDNA re-arrangements can be detected in patients with mtDNA deletions: duplications may be a transient intermediate form. Hum Mol Genet (1993) 1.29
Direct repeats in the non-coding region of rabbit mitochondrial DNA. Involvement in the generation of intra- and inter-individual heterogeneity. Eur J Biochem (1990) 1.29
Mitochondrial DNA: does more lead to less? Nat Genet (1994) 1.08
Ageing-associated tandem duplications in the D-loop of mitochondrial DNA of human muscle. FEBS Lett (1994) 1.06
Maternally inherited duplication of the mitochondrial genome in a syndrome of proximal tubulopathy, diabetes mellitus, and cerebellar ataxia. Am J Hum Genet (1992) 1.05
In vivo and in vitro evidence for slipped mispairing in mammalian mitochondria. Proc Natl Acad Sci U S A (1993) 1.00
Length variation in mitochondrial DNA of the minnow Cyprinella spiloptera. Genetics (1994) 0.99
Heteroplasmy and polymorphism in the major noncoding region of mitochondrial DNA in Japanese monkeys: association with tandemly repeated sequences. Mol Biol Evol (1991) 0.93
High levels of mitochondrial DNA with an unstable 260-bp duplication in a patient with a mitochondrial myopathy. Neurology (1995) 0.88
Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology (1988) 4.28
A direct repeat is a hotspot for large-scale deletion of human mitochondrial DNA. Science (1989) 3.02
MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol (1992) 2.48
Recombination via flanking direct repeats is a major cause of large-scale deletions of human mitochondrial DNA. Nucleic Acids Res (1990) 2.28
Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy. Cardiovasc Res (2000) 2.26
Cytochrome c oxidase assembly in primates is sensitive to small evolutionary variations in amino acid sequence. Mol Biol Evol (2000) 2.19
Distribution of wild-type and common deletion forms of mtDNA in normal and respiration-deficient muscle fibers from patients with mitochondrial myopathy. Hum Mol Genet (1994) 2.16
Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet (1991) 2.10
Ethical questions in human clinical psychopharmacology: should the focus be on placebo administration? J Psychopharmacol (2008) 2.07
Widespread tissue distribution of mitochondrial DNA deletions in Kearns-Sayre syndrome. Neurology (1990) 1.97
An out-of-frame cytochrome b gene deletion from a patient with parkinsonism is associated with impaired complex III assembly and an increase in free radical production. Ann Neurol (2000) 1.95
Titrating the effects of mitochondrial complex I impairment in the cell physiology. J Biol Chem (1999) 1.92
Mitochondrial encephalomyopathies. Arch Neurol (1993) 1.79
Lack of oxidative phosphorylation and low mitochondrial membrane potential decrease susceptibility to apoptosis and do not modulate the protective effect of Bcl-x(L) in osteosarcoma cells. J Biol Chem (2000) 1.55
Reactive oxygen species and mitochondrial diseases. Semin Cell Dev Biol (2001) 1.53
Serum osteocalcin and bone mineral density at various skeletal sites: a study performed with three different assays. J Lab Clin Med (1997) 1.43
Comments, opinions, and brief case reports: desmopressin test in occult eutopic corticotropin microadenoma. Arch Intern Med (2002) 1.40
Transcription and translation of deleted mitochondrial genomes in Kearns-Sayre syndrome: implications for pathogenesis. Am J Hum Genet (1990) 1.40
Human xenomitochondrial cybrids. Cellular models of mitochondrial complex I deficiency. J Biol Chem (1998) 1.38
A stop-codon mutation in the human mtDNA cytochrome c oxidase I gene disrupts the functional structure of complex IV. Am J Hum Genet (1999) 1.36
Manipulating mitochondrial DNA heteroplasmy by a mitochondrially targeted restriction endonuclease. Hum Mol Genet (2001) 1.32
Expanding the functional human mitochondrial DNA database by the establishment of primate xenomitochondrial cybrids. Proc Natl Acad Sci U S A (1997) 1.31
Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities. Brain Res Mol Brain Res (1997) 1.19
Suppression of a mitochondrial tRNA gene mutation phenotype associated with changes in the nuclear background. Hum Mol Genet (1999) 1.17
In vivo regulation of oxidative phosphorylation in cells harboring a stop-codon mutation in mitochondrial DNA-encoded cytochrome c oxidase subunit I. J Biol Chem (2001) 1.16
A new mtDNA mutation in the tRNA(Lys) gene associated with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet (1992) 1.16
Widespread tissue distribution of a tRNALeu(UUR) mutation in the mitochondrial DNA of a patient with MELAS syndrome. Neurology (1991) 1.16
Extremely high levels of mutant mtDNAs co-localize with cytochrome c oxidase-negative ragged-red fibers in patients harboring a point mutation at nt 3243. Hum Mol Genet (1994) 1.15
Mitochondrial DNA depletion: mutations in thymidine kinase gene with myopathy and SMA. Neurology (2002) 1.14
Immunocytochemical study of dystrophin in muscle cultures from patients with Duchenne muscular dystrophy and unaffected control patients. Am J Pathol (1988) 1.14
Functional constraints of nuclear-mitochondrial DNA interactions in xenomitochondrial rodent cell lines. J Biol Chem (2000) 1.13
Giant dystrophin deletion associated with congenital cataract and mild muscular dystrophy. Neurology (1998) 1.12
Segregation patterns of a novel mutation in the mitochondrial tRNA glutamic acid gene associated with myopathy and diabetes mellitus. Am J Hum Genet (1995) 1.12
Maintenance of human rearranged mitochondrial DNAs in long-term cultured transmitochondrial cell lines. Mol Biol Cell (2000) 1.11
Mitochondrial myopathy of childhood associated with depletion of mitochondrial DNA. Neurology (1992) 1.10
Dominantly inherited mitochondrial myopathy with multiple deletions of mitochondrial DNA: clinical, morphologic, and biochemical studies. Neurology (1991) 1.10
Pathophysiology and fate of hepatocytes in a mouse model of mitochondrial hepatopathies. Gut (2007) 1.09
Cloning of an endangered species (Bos gaurus) using interspecies nuclear transfer. Cloning (2000) 1.09
The mitochondrial tRNA(Leu)(UUR)) mutation in MELAS: a model for pathogenesis. Biochim Biophys Acta (1992) 1.08
A disease-associated G5703A mutation in human mitochondrial DNA causes a conformational change and a marked decrease in steady-state levels of mitochondrial tRNA(Asn). Mol Cell Biol (1997) 1.08
Purification and substrate specificity of heparitinase I and heparitinase II from Flavobacterium heparinum. Analyses of the heparin and heparan sulfate degradation products by 13C NMR spectroscopy. J Biol Chem (1990) 1.06
Organ-specific shifts in mtDNA heteroplasmy following systemic delivery of a mitochondria-targeted restriction endonuclease. Gene Ther (2010) 1.06
Manipulation of mtDNA heteroplasmy in all striated muscles of newborn mice by AAV9-mediated delivery of a mitochondria-targeted restriction endonuclease. Gene Ther (2011) 1.04
A new mutation associated with MELAS is located in a mitochondrial DNA polypeptide-coding gene. Neuromuscul Disord (1995) 1.04
Modulating mtDNA heteroplasmy by mitochondria-targeted restriction endonucleases in a 'differential multiple cleavage-site' model. Gene Ther (2007) 1.02
Mitochondrial DNA background modifies the bioenergetics of NARP/MILS ATP6 mutant cells. Hum Mol Genet (2009) 1.02
Fatal infantile liver failure associated with mitochondrial DNA depletion. J Pediatr (1992) 1.01
Melancholia agitata and mixed depression. Acta Psychiatr Scand Suppl (2007) 0.97
Cardiomyopathy may be the only clinical manifestation in female carriers of Duchenne muscular dystrophy. Neurology (1993) 0.96
New morphological approaches to the study of mitochondrial encephalomyopathies. Brain Pathol (1992) 0.95
Contrast echocardiography for pulmonary arteriovenous malformations screening: does any bubble matter? Eur J Echocardiogr (2008) 0.92
Further evidence for mitochondrial dysfunction in progressive supranuclear palsy. Exp Neurol (2001) 0.91
Efficient and specific amplification of identified partial duplications of human mitochondrial DNA by long PCR. Biochim Biophys Acta (1996) 0.90
Annual skeletal balance and metabolic bone marker changes in healthy early postmenopausal women: results of a prospective study. Bone (2000) 0.89
Immunologic evaluation during the first year of life of infants born to cyclosporine-treated female kidney transplant recipients: analysis of lymphocyte subpopulations and immunoglobulin serum levels. Transplantation (2000) 0.89
Rho(0) tumor cells: a model for studying whether mitochondria are targets for rhodamine 123, doxorubicin, and other drugs. Biochem Pharmacol (2000) 0.89
Mitochondrial encephalomyopathies. Neurol Clin (1990) 0.88
Clinical and morphologic features of a myopathy associated with a point mutation in the mitochondrial tRNA(Pro) gene. Neurology (1994) 0.88
High levels of mitochondrial DNA with an unstable 260-bp duplication in a patient with a mitochondrial myopathy. Neurology (1995) 0.88
Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease. J Thromb Haemost (2014) 0.88
Identification of a mutation in the mitochondrial tRNA(Cys) gene associated with mitochondrial encephalopathy. Hum Mutat (1996) 0.87
Deletions of mitochondrial DNA in Kearns-Sayre syndrome. 1988. Neurology (1998) 0.87
Deletion of mitochondrial DNA in patients with combined features of Kearns-Sayre and MELAS syndromes. Ann Neurol (1991) 0.87
Structural and functional mitochondrial abnormalities associated with high levels of partially deleted mitochondrial DNAs in somatic cell hybrids. Somat Cell Mol Genet (1992) 0.86
Studies on dapsone induced haemolytic anaemia. I. Methaemoglobin production and G-6-PD activity in correlation with dapsone dosage. Br J Dermatol (1979) 0.85
In situ identification of mononuclear cells infiltrating cutaneous carcinoma: an immuno-histochemical study. Acta Derm Venereol (1979) 0.84
Detection and analysis of mitochondrial DNA deletions by whole genome PCR. Biochem Mol Med (1996) 0.84
Disorders associated with depletion of mitochondrial DNA. Brain Pathol (1992) 0.84
A MERRF/PEO overlap syndrome associated with the mitochondrial DNA 3243 mutation. Neurology (1996) 0.83
Retinol binding protein in normal human skin and in cutaneous disorders. Br J Dermatol (1981) 0.82
Imbalance in phenotypic expression of T cell subpopulations during different evolutional stages of lichen planus lesions. Acta Derm Venereol (1983) 0.82
Oxidative phosphorylation dysfunction does not increase the rate of accumulation of age-related mtDNA deletions in skeletal muscle. Mutat Res (1997) 0.82
Isolation and characterization of a heparin with high anticoagulant activity from Anomalocardia brasiliana. Biochim Biophys Acta (1985) 0.81
Dopamine transporter mRNA in autopsy studies of chronic cocaine users. Brain Res Mol Brain Res (1999) 0.81
Sequence analysis of the diabetes-protective human leukocyte antigen-DQB1*0602 allele in unaffected, islet cell antibody-positive first degree relatives and in rare patients with type 1 diabetes. J Clin Endocrinol Metab (1999) 0.81
Mitochondrial DNA defects in Brazilian patients with chronic progressive external ophthalmoplegia. J Neurol Sci (1997) 0.80
Effect of naloxone on somatostatin inhibition of arginine vasopressin response to physical exercise in normal men. J Neural Transm (Vienna) (2008) 0.80
Duplication and triplication with staggered breakpoints in human mitochondrial DNA. Biochim Biophys Acta (1998) 0.80
[Mibelli's porokeratosis and actinic keratosis. Clinical, histological and ultrastructural considerations apropos of 1 case with degeneration]. Ann Dermatol Venereol (1979) 0.79
Free fatty acids inhibit adrenocorticotropin and cortisol secretion stimulated by physical exercise in normal men. Clin Endocrinol (Oxf) (2007) 0.79
Elevation of transaminases as an early sign of late-onset glycogenosis type II. Eur J Pediatr (1993) 0.79
A novel mitochondrial G8313A mutation associated with prominent initial gastrointestinal symptoms and progressive encephaloneuropathy. Pediatr Res (1997) 0.79
Ophthalmoplegia, demyelinating neuropathy, leukoencephalopathy, myopathy, and gastrointestinal dysfunction with multiple deletions of mitochondrial DNA: a mitochondrial multisystem disorder in search of a name. Muscle Nerve (1994) 0.79
Dysfunctional mitochondrial respiration in the wobbler mouse brain. Neurosci Lett (2001) 0.79
A helicase is born. Nat Genet (2001) 0.79
[Study of pollen of allergologic significance in the urban atmosphere of Parma in the years 1983-1984]. Acta Biomed Ateneo Parmense (1989) 0.79
Cybrids in Alzheimer's disease: a cellular model of the disease? Neurology (1998) 0.78
Structure of heparan sulfate: identification of variable and constant oligosaccharide domains in eight heparan sulfates of different origins. Cell Mol Biol (Noisy-le-grand) (1998) 0.78
Magnetic resonance measures in Alzheimer disease: their utility in early diagnosis and evaluating disease progression. Alzheimer Dis Assoc Disord (1999) 0.78
Mitochondrial encephalomyopathies: biochemical approach. Rev Neurol (Paris) (1991) 0.78
Pseudopseudohypoparathyroidism associated with idiopathic growth hormone deficiency. Role of treatment with biosynthetic growth hormone. J Endocrinol Invest (1993) 0.78
Mechanism of the oxidation reaction of deoxyhemoglobin as studied by isolation of the intermediates suggests tertiary structure dependent cooperativity. Biochemistry (1993) 0.78
Growth hormone (GH) and the immune system: impaired phagocytic function in children with idiopathic GH deficiency is corrected by treatment with biosynthetic GH. J Pediatr Endocrinol (1995) 0.78
Pregnancy in renal transplantation: immunologic evaluation of neonates from mothers with transplanted kidney. Transpl Immunol (2002) 0.78
A splice junction mutation in the alpha(M) gene of phosphorylase kinase in a patient with myopathy. Biochem Biophys Res Commun (1998) 0.77
Effect of oxytocin on nitric oxide activity controlling gonadotropin secretion in humans. Eur J Clin Invest (2003) 0.77
Alzheimer's disease: patterns of cognitive impairment at different levels of disease severity. J Neurol Sci (1998) 0.77